Which describes you?


Product?

The link you selected will take you away from this site to one that is not owned or controlled by Genentech and Biogen Idec. Genentech and Biogen Idec are not part of the site. Nor does it control the content. Genentech does not guarantee the information on the page. Your use of third-party websites is at your own risk and is subject to the terms and conditions of use for such sites. 

The information contained in this section of the site is for U.S. health care professionals only. Please click "OK" if you are a U.S. health care professional.

Do you need to know more about what we offer for each of our products?

Do you want to know more about Rituxan Access Solutions? To see what we offer, click here.

 

Questions and Answers About Rituxan Access Solutions


If this is your first time working with Rituxan® Access Solutions - or even if you've worked with us before-you are bound to have some questions about how our programs work for treatment with Rituxan® (rituximab). We've assembled a list of questions we are asked most often and provided the answers you might need.

What is Rituxan Access Solutions?

Genentech makes medicines like Rituxan for people who have serious health problems. We think these medicines should be available to all people who need them. We can assist you and your doctor's office in many ways. We help with support for coverage and payment. We also give patient assistance support and have information to help you.


How do I contact Rituxan Access Solutions?

The quickest way to contact us is by calling our toll-free telephone number at (888) 249-4918. Our toll-free fax number is (888) 249-4919. Our mailing address is:

Rituxan Access Solutions
1 DNA Way, Mail Stop #210
South San Francisco, CA 94080-4990


When does Rituxan Access Solutions start helping with my patient's case?

We can start helping to connect your patient to Rituxan as soon as we have received the completed required forms.


Should I contact Rituxan Access Solutions about general questions about Rituxan?

No. You should direct your questions about Rituxan to your Clinical Sales Representative. We can answer questions only about access and reimbursement.


Does Rituxan Access Solutions bill claims?

We do not provide billing services, but we can help you with billing/coding issues or denied claims.


When should I refer my patient to Rituxan Access Solutions for help?

At any point in the process of obtaining Rituxan for your patient - whether you've just decided to prescribe it for your patient, if you've submitted a prior authorization (PA) request to the insurer and Rituxan wasn't approved or if your patient has been on Rituxan but is now having insurance issues.


How do I refer my patient to Rituxan Access Solutions?

Please see How to Refer Patients to Rituxan Access Solutions for more information.


Do I need to register my Rituxan patients with you before treatment begins?

No. There is no need to preregister a patient with us. However, you do need to enroll a patient for our help with issues of access and reimbursement. Rituxan Access Solutions is a voluntary program offered at no charge to you or your patients.


Why does Rituxan Access Solutions ask for medical documentation?

We provide access and reimbursement support for a patient based on the patient's clinical situation and the insurer's coverage guidelines. Medical documentation is needed during prior authorization and/or the appeals process.


Can Rituxan Access Solutions assist with co-pay issues?

Yes. We can help with co-pay issues. We can explore alternative coverage options and available resources in the community to help with co-pays. We can refer the patient to an independent, non-profit organization offering assistance for people prescribed Rituxan. (We do not influence or control the operations of these organizations. Nor can we guarantee they will provide co-pay assistance.) Second, we offer the Rituxan Co-pay Card Program for eligible patients who have said they need assistance with co-pays. 


Is there assistance for uninsured patients who have been prescribed Rituxan?

The Genentech®Access to Care Foundation provides help for qualified patients. These include patients who are uninsured or whose health plans have denied payment for Rituxan. They must meet certain financial and medical requirements.


INDICATIONS

RITUXAN® (Rituximab) is indicated for the treatment of patients with:

  • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy
  • Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy
  • Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens
  • Previously untreated CD20-positive CLL in combination with FC chemotherapy
  • Previously treated CD20-positive CLL in combination with FC chemotherapy

People with serious infections should not receive RITUXAN

IMPORTANT SAFETY INFORMATION
RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).

RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.

The most common side effects of RITUXAN seen in patients with non-Hodgkin's lymphoma were infusion reactions, fever, chills, low white blood cells, infections, body aches, and tiredness. The most common side effects of RITUXAN in patients with chronic lymphocytic leukemia were infusion reactions and low white blood cells. Before starting treatment with RITUXAN it is important to talk to your doctor about your medical history.

Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including the Medication Guide.

Rituxan® and its logo are trademarks of Biogen Idec, Inc.
The Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.

© 2010 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.